IPP Bureau
Eugia Pharma launches Pomalidomide capsules in US market
By IPP Bureau - March 06, 2026
NATCO announces launch of Pomalidomide capsules in US
By IPP Bureau - March 05, 2026
It is also approved for?AIDS-related Kaposi sarcoma?after failure of highly active antiretroviral therapy, as well as for HIV-negative adult patients with Kaposi sarcoma
Ind-Swift earns EcoVadis silver medal for sustainability excellence
By IPP Bureau - March 05, 2026
The Silver Medal recognizes strong performance across sustainability, ethics, environment, labour & human rights, and responsible procurement
PK Healthcare granted accreditation under 6th edition by NABH
By IPP Bureau - March 05, 2026
The 6th Edition NABH framework places strong emphasis on patient safety protocols, robust clinical governance, risk management systems
Shyamakant Giri resigns as CEO of Gland Pharma
By IPP Bureau - March 05, 2026
Giri stated he is stepping down to pursue new opportunities after careful consideration
Teva and Blackstone Life Sciences strike $400m deal to advance promising IBD therapy
By IPP Bureau - March 05, 2026
The funding will be spread over four years, with BXLS also eligible for regulatory and commercial milestones, plus royalties on worldwide sales
Moderna strikes $950 million global settlement with Arbutus & Genevant, clears legal hurdles for vaccine pipeline
By IPP Bureau - March 05, 2026
Moderna will appeal to the Federal Circuit to assert that its government-contractor immunity limits liability under federal law
KIMS Hospitals launches India’s first adaptive deep brain stimulation for Parkinson’s patients
By IPP Bureau - March 05, 2026
Built on the Percept Platform and enhanced with BrainSense technology, the system can adjust stimulation levels in real time, responding to brain signals without manual intervention
MGM Hospitals deliver life-saving CAR-T therapy to elderly cancer patients in Chennai
By IPP Bureau - March 05, 2026
A next-generation, cell-based immunotherapy, CAR-T therapy engineers a patient’s own immune cells to detect and destroy cancer
Rapid medical weight loss fuels surge in facial aesthetics, Allergan data shows
By IPP Bureau - March 05, 2026
Recent data reveal that patients undergoing MWL are entering aesthetic practices with unique needs tied to facial structure and skin quality
Theravance Biopharma winds down Ampreloxetine programme after Phase 3 miss
By IPP Bureau - March 05, 2026
Syntis Bio launches first patient dosing for groundbreaking oral obesity therapy
By IPP Bureau - March 05, 2026
SYNT-101 is a once-daily oral pill engineered to redirect nutrient absorption beyond the small intestine’s duodenum
Glenmark bags FDA nod for generic asthma inhaler with 180-day exclusivity
By IPP Bureau - March 05, 2026
